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Vitamin D is a pleiotropic hormone essential for optimal health. Vitamin D status has been associated with diseases involving dysregulation of the immune, cardiovascular, and respiratory systems. Levels of 25-hydroxy Vitamin D (25\[OH\]D) are most often used to assess the adequacy of Vitamin D stores. It is less clear what impact deficiency has on the critically ill. Critical illness in children is a major cause of significant health-care utilization and mortality worldwide. The concern is especially understandable in developing countries with limited resources. The association of Vitamin D deficiency (VDD) in critically ill adults has been well-studied, with a recent meta-analysis demonstrating a significant increase in infection rate, sepsis, and mortality in deficient patients.\[[@ref1]\] In comparison, the importance of Vitamin D in pediatric critical illness has been much less studied. Recent research of critically ill children has demonstrated that VDD is common and a few studies have also identified that VDD is associated with more severe illness and a longer stay in the pediatric intensive care unit (PICU).\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7]\] No consensus has as yet been reached regarding the optimal definition of VDD nor the threshold levels to define health benefits. Due to the lack of interventional studies to show that administration of Vitamin D improves clinical outcomes, opinion is still divided as to whether it is association or causality. The evidence of Vitamin D status in critically ill children is lacking from developing countries, especially Turkey. Therefore, the objective of this study was to assess the prevalence of VDD in critically ill children admitted to the PICU, to assess the determinants of Vitamin D status and to assess the association between Vitamin D status and illness severity.
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=================================================

This was a retrospective study in which all children aged ≤18 years (1 month to ≤18 years) admitted to the 12 bed medical-surgical PICUs from June 2014 to November 2015 were screened. There were 570 total admissions to the PICU during the study. All patients admitted to the PICU who had levels of 25(OH)D available within 24 h of admission were included in the study. Only the first PICU admission of each patient was included in the study. 25(OH)D levels were collected randomly during the first 24 h of admission to the PICU.

The patient demographic and clinical data were recorded on PICU admission, including age, gender, body mass index (BMI) (kg/m^2^), underlying illness, reason for admission, season and history of Vitamin D supplementation. Laboratory variables obtained during the first 24 h of hospital admission which included serum levels of total calcium, ionized calcium, phosphate, magnesium and 25(OH)D were analyzed.

Blood samples were drawn during routine phlebotomy on admission to the PICU. All tests were performed by routine methods employed in the biochemistry laboratory of our university hospital. 25(OH)D was measured once a week. Samples were protected from exposure to sunlight, centrifuged and stored under refrigeration until processing. The level of 25(OH)D was measured using chromatography together with the tandem mass spectrometry method (Zivak Technologies, Kocaeli, Turkey) and was reported in ng/mL. VDD was defined as a level of 25(OH)D \<20 ng/ml.\[[@ref5][@ref6][@ref7]\] All the paediatric cases included in the study were divided into two groups as Vitamin D sufficient (25\[OH\]D ≥20 ng/ml) or Vitamin D deficient (25\[OH\]D \<20 ng/ml).

The primary outcome measure was the occurrence of VDD in critically ill children. Secondary outcomes were to assess the determinants of Vitamin D status and to compare Vitamin D deficient and sufficient cases in respect of severity of illness. The variables used as measures of illness severity included the pediatric risk of mortality (PRISM III) score, catecholamine requirements, mechanical ventilation, PICU length of stay (LOS), and mortality. Sepsis was defined as a systemic inflammatory response syndrome in the presence of suspected or confirmed infection by any pathogen in the blood or cerebrospinal fluid.\[[@ref8]\] This study was approved by the Local Ethics Committee of Ondokuz May+s University (Samsun, Turkey).

The statistical analyses of the data obtained in the study were made using SPSS 21 software (IBM Corp. in Armonk, NY, USA). The evaluation was made under the 3 headings of descriptive, single variable and multivariable analysis methods. Numerical data were stated as median (interquartile range \[IQR\]) and mean ± standard deviation (SD). Categorical data were stated as number (n) and percentage (%).

Conformity of the data to normal distribution was evaluated. In the comparisons between independent groups, for numerical variables not showing normal distribution, the Mann Whitney U-test was used for the comparisons between two groups and for more than two groups, Kruskal-Wallis nonparametric variance analysis was applied. In the comparison of categorical data between independent groups, Chi-square statistics were applied. In the multi-variable analyses, the Cox regression model was applied for censored time-to-event data, a logistic regression model for dichotomsed data when mortality was examined, and a multi-variable linear regression model in the quantitative evaluation of Vitamin D level. In all the statistical evaluations of the study, a 2-way hypothesis structure and 5% Type-1 error level were used.
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The baseline characteristics of the cohort are shown in [Table 1](#T1){ref-type="table"}. The study included a total of 205 critically ill children with a median age of 47 months (IQR 11--125 months). Seventy-eight patients (38%) were younger than 2 years. The main reasons for PICU admission were neurologic diseases (43.21%), respiratory tract infections (41.20%) and sepsis (30, 14.6%). According to the family history, 55 patients were taking Vitamin D supplementation before admission, and the majority (*n* = 43, 78.2%) were younger than 2 years. The mean 25(OH)D level of the whole groups was 19.9 ± 11.8 ng/ml. VDD (25\[OH\]D levels \<20 ng/ml) was determined in 120 (58.5%) children with a higher prevalence (76.7%) in children older than 2 years. A history of Vitamin D supplementation was associated with higher 25(OH) vit D levels. The mean 25(OH)D levels were higher in children with a history of Vitamin D supplementation compared to children with no Vitamin D supplementation (29.5 ± 13.1 ng/mL vs. 16.5 ± 9.2 ng/mL, *P* \< 0.001). The mean 25(OH)vitD levels were lower (16.7 ± 11.1 ng/ml) in the children who had sepsis at admission compared to other critically ill patient groups (20.6 ± 12.2), but the difference was not statistically significant (*P* = 0.08). Twenty-five (12.1%) patients died during PICU hospitalization. Although the mean 25(OH)D levels were lower in the children who died compared to those who survived \[18.5 ± 9.4 ng/ml vs. 20.1 ± 12.2 ng/ml\], the difference was not statistically significant (*P* = 0.778).

###### 

Baseline demographic and clinical characteristics of children enrolled in the study
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The characteristics of Vitamin D deficient and sufficient children were compared \[[Table 2](#T2){ref-type="table"}\]. There were no gender differences between the groups, but the Vitamin D deficient patients were older and heavier. Vitamin D deficient children had a significantly higher median age compared to the Vitamin D sufficient children (73 months \[IQR: 29.5--158\] vs. 14 months \[IQR: 7--79\]) (*P* \< 0.001) Linear regression analysis demonstrated that for every 1 month increase in age there was a 0.353 ng/mL decrease in Vitamin D level (95% confidence interval \[CI\]: −0.082--−0.038). Vitamin D deficient children had a significantly higher median weight compared to Vitamin D sufficient children (20 kg \[11--40\] vs. 10 kg \[6.5--20\]) (*P* \< 0.001) Vitamin Ddeficient patients had higher BMI values (17 \[14.2--19.7\] kg/m^2^ vs. 15.9 \[13.5--18.6\] kg/m^2^), but there was no statistically significant difference (*P* = 0.0149). Of the total patients hospitalized during the autumn and winter months, 76% were considered to be Vitamin D deficient, whereas in the sunnier seasons (spring and summer), almost 50% of patients were considered as Vitamin D deficient (*P* = 0.002). The underlying disease incidence was slightly higher in the Vitamin D sufficient patients (57.6% vs. 52.5%; *P* = 0.466). Although catecholamine requirements were significantly higher in Vitamin D deficient patients (37.5% vs. 23.5% *P* = 0.034), no statistically significant difference was determined between the groups in respect of main admission reasons, underlying illnesses, PICU LOS, PRISM III score, need for mechanical ventilation and mortality. There was no association between the admission levels of ionized calcium, phosphate, magnesium and Vitamin D status. However, the lowest measured calcium within the first 24 h was significantly lower in children with VDD (9 ± 1 mg/dL vs. 9.5 ± 0.9 mg/dL) (*P* \< 0.001).

###### 

Demographic, clinical, and laboratory data in patients with or without Vitamin D deficiency
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In the multivariable linear regression model, only patient age (relative risk \[RR\]: −0.353; 95% CI: −0.084--−0.036; *P* \< 0.001) and winter season admission (RR: −0.247; 95% CI: −11.492--−3.366; *P* \< 0.001) were identified as statistically associated with VDD. The established risk factors of BMI, gender, and underlying illnesses were not independently associated with VDD. With logistic regression analysis, the factors that were significantly associated with mortality included catecholamine requirements (OR: 41.952; 95% CI: 4.944--355.998; *P* = 0.001) and PRISM-III score (OR: 1.162; 95% CI: 1.057--1.278; *P* = 0.002). The other factors of the presence of underlying illness, level of Vitamin D, need for mechanical ventilation, and presence of sepsis at admission were not determined to be associated with mortality \[[Table 3](#T3){ref-type="table"}\].
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Multiple logistic regression models assessing variables associated with mortality
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The data from this study strongly suggest that the majority (58.5%) of critically ill Turkish children are deficient in Vitamin D (25\[OH\]vitD levels \<20 ng/ml) at admission. The prevelance of VDD (76.7%) was higher in children older than 2 years. These levels are considerably higher than the rate of 40% reported in a previous study of 440 Turkish children and adolescents aged between 0 and 16 years who presented at the outpatient clinic.\[[@ref9]\] The available evidence suggests occurrence ranging from approximately 30% to 84% in critically ill children.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7]\] The wide differences in the occurrence of VDD in different studies may be due to differences in the populations studied, sunlight exposure, weather, dietary intake, Vitamin D supplementation, genotype variation in the proteins involved in Vitamin D transportation, functioning and metabolism, different methods of measuring 25(OH)D, and different cut-off values.\[[@ref10]\]

A previously described inverse correlation between 25(OH)vitD levels and age was confirmed by the present study. The data of the current study demonstrate that the prevalence of VDD in patients hospitalized during the fall and winter was significantly higher than in sunnier months. Furthermore, the multivariable linear regression model only identified patient age and winter season admission as statistically associated with VDD. Similarly, in healthy children, factors consistently associated with 25(OH)vitD levels have been reported to be age, the season of the year, and dietary calcium intake.\[[@ref11]\] Unfortunately, there were no available data regarding calcium intake of the children in the current study.

Vitamin D plays a physiological role in regulating immunity, and in thermodulation of T- and B-cell activity, cytokine production, and the expression of antimicrobial peptides.\[[@ref12][@ref13][@ref14]\] The data from this study showed that patients with sepsis diagnosed at admission had a lower 25(OH)D level; although, the difference was not statistically significant. Madden *et al*.\[[@ref2]\] demonstrated that children admitted to the PICU with severe septic shock had lower serum 25(OH)D levels than other critically ill children in the PICU. Another study from Ireland showed that children admitted to the PICU with suspected sepsis had lower 25(OH)D than a control group and inadequate 25(OH)D status was associated with confirmed sepsis and poor outcomes.\[[@ref15]\] Data from adults in a recent meta-analysis reported a significant increase in infection rate and sepsis.\[[@ref1]\]

Underlying illnesses could lead to reduced Vitamin D status through abnormal diet, altered metabolism, or reduced environmental ultraviolet exposure. In contrast to expectations, underlying illnesses had no significant influence on Vitamin D status at PICU admission, as has been noted in previous studies of critical illness in pediatric patients.\[[@ref2][@ref3]\] In the current study, no associations were observed between Vitamin D status and PRISM III score. Similarly, some previous studies have not found any association between VDD and severity score.\[[@ref4][@ref5][@ref16]\] However, McNally *et al*.\[[@ref3]\] reported that with every additional point increase in PRISM III score, the likelihood of VDD increased by 8%. A somewhat similar observation was reported by Madden *et al*.\[[@ref2]\] who reported an OR of 1.19 (95% CI 1.10--1.28) for a 1-quartile rise in PRISM III score per 5 ng/ml decrease in 25(OH)D levels. This inconsistency of association could be explained by the heterogeneous patient population in different studies and variations in the tools used to assess severity.

Furthermore, no difference was determined between the low and normal 25(OH)D groups of the current study in respect of the need for ventilation and PICU LOS, which was in agreement with the data reported by Rippel *et al*.\[[@ref4]\] and Rey *et al*.\[[@ref5]\] However, McNally *et al*.\[[@ref3]\] and Sankar *et al*.\[[@ref7]\] found VDD to be associated with a longer LOS. Geographic and ethnic differences, different reasons for PICU admissions, and variations in patient responses to acute stress and critical illness could explain the differences between studies.

The association between Vitamin D status and myocardial dysfunction, heart failure, and sudden cardiac death is a novel finding.\[[@ref17][@ref18][@ref19]\] The current study results demonstrated that patients with VDD had significantly higher catecholamine requirements. Madden *et al*.\[[@ref2]\] also observed that patients who received catecholamine had lower levels of 25(OH)D than those who did not median 19.8 versus 24.3 ng/ml, *P* \< 0.0001 and an increased use of vasopressors was correlated with decreasing 25(OH)D levels (*r* = 2.19, *P* \< 0.0001. Similarly, McNally *et al*.\[[@ref3]\] reported lower mean (SD) 25(OH)D levels in patients who required catecholamine infusion (45\[[@ref19]\] nmol/L vs. 38.5\[[@ref16]\] nmol/L, *P* = 0.006) Other studies have found no association between VDD and requirements for catecholamine.\[[@ref4][@ref5]\]

No significant association was determined in the current study between Vitamin D status and mortality. Vitamin D levels did not differ in survivors and nonsurvivors and in the logistic regression analysis, VDD was not associated with mortality. Adult studies have found a higher risk of mortality in patients with VDD.\[[@ref20][@ref21][@ref22]\] McNally *et al*.\[[@ref3]\] found that on multivariate regression, a 25(OH)D concentration \<50 nmol/L was independently associated with a PICU mortality rate of 1.5% (5/326) and all 5 deceased patients had VDD. Similarly, Ayulo *et al*.\[[@ref16]\] reported that 5 of 6 deaths were in patients with VDD. Other studies have found no association between VDD and mortality.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
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In conclusion, in a population of children from the north of Turkey, VDD incidence was seen to be high at PICU admission. To the best of our knowledge, this is the first study related to 25(OH)D levels in critically ill pediatric patients in Turkey. The patients determined with VDD were older and heavier and were more likely to receive a catecholamine. No significant correlation was found between other markers of illness severity, including mortality, and Vitamin D level. Further studies are required to establish a causal link between Vitamin D deficiency state and critical illness.
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